Cargando…

Thrombopoietin protects hematopoietic stem cells from retrotransposon-mediated damage by promoting an antiviral response

Maintenance of genomic integrity is crucial for the preservation of hematopoietic stem cell (HSC) potential. Retrotransposons, spreading in the genome through an RNA intermediate, have been associated with loss of self-renewal, aging, and DNA damage. However, their role in HSCs has not been addresse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbieri, Daniela, Elvira-Matelot, Emilie, Pelinski, Yanis, Genève, Laetitia, de Laval, Bérengère, Yogarajah, Gayathri, Pecquet, Christian, Constantinescu, Stefan N., Porteu, Françoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940259/ https://www.ncbi.nlm.nih.gov/pubmed/29615469 http://dx.doi.org/10.1084/jem.20170997

Ejemplares similares

NF-κB signaling controls H3K9me3 levels at intronic LINE-1 and hematopoietic stem cell genes in cis
por: Pelinski, Yanis, et al.
Publicado: (2022)

The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin
por: Varghese, Leila N., et al.
Publicado: (2017)

Thrombopoietin receptor is required for the oncogenic function of CALR mutants
por: Nivarthi, H, et al.
Publicado: (2016)

Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers
por: Defour, Jean-Philippe, et al.
Publicado: (2023)

Hematopoietic stem cells temporally transition to thrombopoietin dependence in the fetal liver
por: Lee, Yeojin, et al.
Publicado: (2022)

Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation
por: Papadopoulos, Nicolas, et al.
Publicado: (2023)

Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation
por: Gao, Longfei, et al.
Publicado: (2021)

Thrombopoietin maintains cell numbers of hematopoietic stem and progenitor cells with megakaryopoietic potential
por: O’Neill, Aled, et al.
Publicado: (2020)

Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation
por: Wang, Chao, et al.
Publicado: (2015)

The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells
por: Ninos, John M, et al.
Publicado: (2006)

Thrombopoietin enhances hematopoietic stem and progenitor cell homing by impeding matrix metalloproteinase 9 expression
por: Liu, Yiming, et al.
Publicado: (2020)

Thrombopoietin as Biomarker and Mediator of Cardiovascular Damage in Critical Diseases
por: Lupia, Enrico, et al.
Publicado: (2012)

Overproduction of thrombopoietin by BRAFV600E‐mutated mouse hepatocytes and contribution of thrombopoietin to hepatocarcinogenesis
por: Tanaka, Hiroki, et al.
Publicado: (2019)

Extracellular Domain N-Glycosylation Controls Human Thrombopoietin Receptor Cell Surface Levels
por: Albu, Roxana I., et al.
Publicado: (2011)

ERK1 Regulates the Hematopoietic Stem Cell Niches
por: Saulnier, Nathalie, et al.
Publicado: (2012)

Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance
por: Kohlscheen, Saskia, et al.
Publicado: (2015)

Deciphering the Differential Impact of Thrombopoietin/MPL Signaling on Hematopoietic Stem Cell Function in Bone Marrow and Spleen
por: Lee, Sandy, et al.
Publicado: (2023)

Thrombopoietin: tickling the HSC's fancy
por: Kim, Ah Ram, et al.
Publicado: (2017)

Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821)
por: Kumar, Vidya P., et al.
Publicado: (2022)

In and out: Traffic and dynamics of thrombopoietin receptor
por: Roy, Anita, et al.
Publicado: (2021)

Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis
por: Cuccurullo, Alessandra, et al.
Publicado: (2016)

Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia
por: Zhang, Ke, et al.
Publicado: (2018)

P1397: CHRONICALLY REDUCED LEVELS OF THROMBOPOIETIN IMPAIR HEMATOPOIETIC STEM CELL FUNCTION AND MEGAKARYOCYTE BONE MARROW NICHE
por: Aprile, A., et al.
Publicado: (2022)

Thrombopoietin and its receptor in normal and neoplastic hematopoiesis
por: Kaushansky, Kenneth
Publicado: (2016)

Thrombopoietin Secretion by Human Ovarian Cancer Cells
por: Besbes, Samaher, et al.
Publicado: (2017)

Thrombopoietin receptor agonists: ten years later
por: Ghanima, Waleed, et al.
Publicado: (2019)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
por: Nakai, Kensaku, et al.
Publicado: (2022)

Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
por: Bastida, José María, et al.
Publicado: (2021)

Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin
Publicado: (1996)

Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma
por: Kiang, Juliann G., et al.
Publicado: (2017)

Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
por: Gu, Jingli, et al.
Publicado: (2021)

PB2505: THERAPEUTIC PHLEBOTOMY INSTANTLY AFFECTS BLOOD PARAMETERS AND VISCOCITY IN SICKLE CELL DISEASE PATIENTS
por: Jebali, Amna, et al.
Publicado: (2023)

CD150-dependent hematopoietic stem cell sensing of Brucella instructs myeloid commitment
por: Hysenaj, Lisiena, et al.
Publicado: (2023)

Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin
Publicado: (1996)

Thrombopoietin may enhance ventilator-induced lung injury
por: Del Sorbo, LD, et al.
Publicado: (2011)

Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
por: Garzon, Angelica Maria, et al.
Publicado: (2015)

Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling
por: Au, Amanda E., et al.
Publicado: (2017)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
por: Pecci, Alessandro, et al.
Publicado: (2017)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
por: Nilles, Kathy M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a4cp80fplvtstdfk7acbb6vo0f